Uptake of Risk‐Reducing Salpingo‐Oophorectomy and Gynaecologic Surveillance Among Germline BRCA Pathogenic Variants Carriers

ABSTRACT Introduction Risk‐reducing salpingo‐oophorectomy (RRSO) is recommended by international guidelines in women with BRCA1/2 germline pathogenic variants (PV) to prevent ovarian cancer. Despite the solid recommendation, women frequently refuse surgery and uptake rates reported in the literature...

Full description

Saved in:
Bibliographic Details
Main Authors: Alessandra Inzoli, Serena Negri, Cristina Dell'Oro, Clarissa Costa, Liliana Marchetta, Mariaclara Boccadutri, Simona Fumagalli, Gaia Roversi, Elena Maria Sala, Chiara Celi, Valentina Rossi, Robert Fruscio
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.70321
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846127058543968256
author Alessandra Inzoli
Serena Negri
Cristina Dell'Oro
Clarissa Costa
Liliana Marchetta
Mariaclara Boccadutri
Simona Fumagalli
Gaia Roversi
Elena Maria Sala
Chiara Celi
Valentina Rossi
Robert Fruscio
author_facet Alessandra Inzoli
Serena Negri
Cristina Dell'Oro
Clarissa Costa
Liliana Marchetta
Mariaclara Boccadutri
Simona Fumagalli
Gaia Roversi
Elena Maria Sala
Chiara Celi
Valentina Rossi
Robert Fruscio
author_sort Alessandra Inzoli
collection DOAJ
description ABSTRACT Introduction Risk‐reducing salpingo‐oophorectomy (RRSO) is recommended by international guidelines in women with BRCA1/2 germline pathogenic variants (PV) to prevent ovarian cancer. Despite the solid recommendation, women frequently refuse surgery and uptake rates reported in the literature are diverse. This study analyses the uptake rate of RRSO in BRCA 1/2 PV‐carriers referred to a specialised referral centre for first counselling and investigate personal factors linked to the decision. Methods This is a single‐centre prospective study of BRCA1/2 PV‐carriers referred for the first counselling to IRCCS Fondazione San Gerardo de’ Tintori (Monza, Italy) between January 2010 and May 2023. Depending on individual characteristics, women were either proposed RRSO or surveillance, consisting of transvaginal ultrasound and CA125 measurement twice per year according to Regional guidelines. Women within the centre have access to a clinical psychologist, a nutritional consult and treatment of menopausal atrophy with diode vaginal laser. The primary endpoint of the study was the uptake rate of RRSO. The secondary objective was to evaluate the main reasons for refusing surgery. Results Among the 287 women included, surgery was proposed to 205 women either at first counselling or during surveillance and was accepted by 197, with an uptake rate of 96.1%. 17.25% of women met the psychologist before or after surgery. The main reasons for refusing RRSO were fear of iatrogenic menopause and childbearing desire. Conclusion This study shows a high uptake rate of RRSO in BRCA PV‐carriers. We believe that the presence of a dedicated outpatient clinic with a multidisciplinary team contributes decisively to our results. Gynaecologic surveillance, as though not beneficial in terms of oncological prevention, may play a significant role in encouraging women with BRCA PV to opt for risk‐reducing surgery.
format Article
id doaj-art-f2788113e108497c8e00f2ebcde3bd0f
institution Kabale University
issn 2045-7634
language English
publishDate 2024-12-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj-art-f2788113e108497c8e00f2ebcde3bd0f2024-12-12T05:38:32ZengWileyCancer Medicine2045-76342024-12-011323n/an/a10.1002/cam4.70321Uptake of Risk‐Reducing Salpingo‐Oophorectomy and Gynaecologic Surveillance Among Germline BRCA Pathogenic Variants CarriersAlessandra Inzoli0Serena Negri1Cristina Dell'Oro2Clarissa Costa3Liliana Marchetta4Mariaclara Boccadutri5Simona Fumagalli6Gaia Roversi7Elena Maria Sala8Chiara Celi9Valentina Rossi10Robert Fruscio11Department of Medicine and Surgery University of Milan‐Bicocca Milan ItalyDepartment of Medicine and Surgery University of Milan‐Bicocca Milan ItalyDepartment of Medicine and Surgery University of Milan‐Bicocca Milan ItalyDepartment of Medicine and Surgery University of Milan‐Bicocca Milan ItalyDepartment of Medicine and Surgery University of Milan‐Bicocca Milan ItalyDepartment of Medicine and Surgery University of Milan‐Bicocca Milan ItalyDepartment of Medicine and Surgery University of Milan‐Bicocca Milan ItalyDepartment of Medicine and Surgery University of Milan‐Bicocca Milan ItalyMedical Genetics Fondazione IRCCS San Gerardo dei Tintori Monza ItalyClinical Psychology Unit IRCCS Fondazione San Gerardo dei Tintori Monza ItalyDepartment of Medicine and Surgery University of Milan‐Bicocca Milan ItalyDepartment of Medicine and Surgery University of Milan‐Bicocca Milan ItalyABSTRACT Introduction Risk‐reducing salpingo‐oophorectomy (RRSO) is recommended by international guidelines in women with BRCA1/2 germline pathogenic variants (PV) to prevent ovarian cancer. Despite the solid recommendation, women frequently refuse surgery and uptake rates reported in the literature are diverse. This study analyses the uptake rate of RRSO in BRCA 1/2 PV‐carriers referred to a specialised referral centre for first counselling and investigate personal factors linked to the decision. Methods This is a single‐centre prospective study of BRCA1/2 PV‐carriers referred for the first counselling to IRCCS Fondazione San Gerardo de’ Tintori (Monza, Italy) between January 2010 and May 2023. Depending on individual characteristics, women were either proposed RRSO or surveillance, consisting of transvaginal ultrasound and CA125 measurement twice per year according to Regional guidelines. Women within the centre have access to a clinical psychologist, a nutritional consult and treatment of menopausal atrophy with diode vaginal laser. The primary endpoint of the study was the uptake rate of RRSO. The secondary objective was to evaluate the main reasons for refusing surgery. Results Among the 287 women included, surgery was proposed to 205 women either at first counselling or during surveillance and was accepted by 197, with an uptake rate of 96.1%. 17.25% of women met the psychologist before or after surgery. The main reasons for refusing RRSO were fear of iatrogenic menopause and childbearing desire. Conclusion This study shows a high uptake rate of RRSO in BRCA PV‐carriers. We believe that the presence of a dedicated outpatient clinic with a multidisciplinary team contributes decisively to our results. Gynaecologic surveillance, as though not beneficial in terms of oncological prevention, may play a significant role in encouraging women with BRCA PV to opt for risk‐reducing surgery.https://doi.org/10.1002/cam4.70321BRCA mutationcancer preventionpsychosocial studieswomen's cancer
spellingShingle Alessandra Inzoli
Serena Negri
Cristina Dell'Oro
Clarissa Costa
Liliana Marchetta
Mariaclara Boccadutri
Simona Fumagalli
Gaia Roversi
Elena Maria Sala
Chiara Celi
Valentina Rossi
Robert Fruscio
Uptake of Risk‐Reducing Salpingo‐Oophorectomy and Gynaecologic Surveillance Among Germline BRCA Pathogenic Variants Carriers
Cancer Medicine
BRCA mutation
cancer prevention
psychosocial studies
women's cancer
title Uptake of Risk‐Reducing Salpingo‐Oophorectomy and Gynaecologic Surveillance Among Germline BRCA Pathogenic Variants Carriers
title_full Uptake of Risk‐Reducing Salpingo‐Oophorectomy and Gynaecologic Surveillance Among Germline BRCA Pathogenic Variants Carriers
title_fullStr Uptake of Risk‐Reducing Salpingo‐Oophorectomy and Gynaecologic Surveillance Among Germline BRCA Pathogenic Variants Carriers
title_full_unstemmed Uptake of Risk‐Reducing Salpingo‐Oophorectomy and Gynaecologic Surveillance Among Germline BRCA Pathogenic Variants Carriers
title_short Uptake of Risk‐Reducing Salpingo‐Oophorectomy and Gynaecologic Surveillance Among Germline BRCA Pathogenic Variants Carriers
title_sort uptake of risk reducing salpingo oophorectomy and gynaecologic surveillance among germline brca pathogenic variants carriers
topic BRCA mutation
cancer prevention
psychosocial studies
women's cancer
url https://doi.org/10.1002/cam4.70321
work_keys_str_mv AT alessandrainzoli uptakeofriskreducingsalpingooophorectomyandgynaecologicsurveillanceamonggermlinebrcapathogenicvariantscarriers
AT serenanegri uptakeofriskreducingsalpingooophorectomyandgynaecologicsurveillanceamonggermlinebrcapathogenicvariantscarriers
AT cristinadelloro uptakeofriskreducingsalpingooophorectomyandgynaecologicsurveillanceamonggermlinebrcapathogenicvariantscarriers
AT clarissacosta uptakeofriskreducingsalpingooophorectomyandgynaecologicsurveillanceamonggermlinebrcapathogenicvariantscarriers
AT lilianamarchetta uptakeofriskreducingsalpingooophorectomyandgynaecologicsurveillanceamonggermlinebrcapathogenicvariantscarriers
AT mariaclaraboccadutri uptakeofriskreducingsalpingooophorectomyandgynaecologicsurveillanceamonggermlinebrcapathogenicvariantscarriers
AT simonafumagalli uptakeofriskreducingsalpingooophorectomyandgynaecologicsurveillanceamonggermlinebrcapathogenicvariantscarriers
AT gaiaroversi uptakeofriskreducingsalpingooophorectomyandgynaecologicsurveillanceamonggermlinebrcapathogenicvariantscarriers
AT elenamariasala uptakeofriskreducingsalpingooophorectomyandgynaecologicsurveillanceamonggermlinebrcapathogenicvariantscarriers
AT chiaraceli uptakeofriskreducingsalpingooophorectomyandgynaecologicsurveillanceamonggermlinebrcapathogenicvariantscarriers
AT valentinarossi uptakeofriskreducingsalpingooophorectomyandgynaecologicsurveillanceamonggermlinebrcapathogenicvariantscarriers
AT robertfruscio uptakeofriskreducingsalpingooophorectomyandgynaecologicsurveillanceamonggermlinebrcapathogenicvariantscarriers